• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多器官功能衰竭患者弥散性血管内凝血的分析——分子标志物的变化及其临床应用

[An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].

作者信息

Gando S, Tedo I

机构信息

Department of Emergency and Critical Care Medicine, Sapporo City General Hospital.

出版信息

Rinsho Ketsueki. 1990 Nov;31(11):1774-9.

PMID:2149574
Abstract

We studied blood coagulation and fibrinolysis in 18 DIC patients with multiple organ failure. Blood was collected three times (1st, 3rd, 6th hospital days) from an indwelling arterial line, and FPA, FPB beta 15-42, alpha 2PI-P1-C, D-dimer, t-PA; Ag, and t-PA activity were measured. 1) Continuous FOY infusion (1.40 +/- 0.07 mg/kg/H) resulted in a statistically significant fall of FPA levels, which however, was still above normal. The FPA levels of the patients whose DIC score was not improved or who had massive hematomas were statistically higher than the patients whose DIC score was improved or without hematomas. 2) FPB beta 15-42, alpha 2PI-Pl-C, and D-dimer remained at consistently high levels following onset of the DIC. A significant positive correlations were seen between these indices; between the FPA and FPB beta 15-42, alpha 2PI-Pl-C. 3) The levels of alpha 2PI-Pl-C were found to be higher in the patients with hematomas than those without hematomas. 4) T-PA; Ag level remained at consistently high during all hospital day. On the other hand, t-PA activity level did not change significantly. There was dissociation between the t-PA; Ag and the t-PA activity. 5) The patients whose DIC score were not improved on the 6th hospital day had higher levels of t-PA; Ag than the patients whose DIC score were improved, but there were no differences in the number of the ischemic organs between these patients. In conclusion, regardless of the continuous FOY infusion some patients revealed the continuous production of thrombin.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了18例伴有多器官功能衰竭的弥散性血管内凝血(DIC)患者的凝血和纤溶情况。通过留置动脉导管在患者住院第1天、第3天和第6天采集三次血液,检测纤维蛋白肽A(FPA)、纤维蛋白肽Bβ15 - 42、α2纤溶酶抑制物 - 纤溶酶复合物(α2PI - P1 - C)、D - 二聚体、组织型纤溶酶原激活物抗原(t - PA; Ag)以及组织型纤溶酶原激活物活性。1)持续输注FOY(1.40±0.07mg/kg/h)使FPA水平有统计学意义的下降,但仍高于正常水平。DIC评分未改善或有大量血肿患者的FPA水平在统计学上高于DIC评分改善或无血肿的患者。2)DIC发病后,纤维蛋白肽Bβ15 - 42、α2PI - Pl - C和D - 二聚体一直维持在高水平。这些指标之间以及FPA与纤维蛋白肽Bβ15 - 42、α2PI - Pl - C之间存在显著正相关。3)有血肿患者的α2PI - Pl - C水平高于无血肿患者。4)在整个住院期间,t - PA; Ag水平一直维持在较高水平。另一方面,t - PA活性水平无显著变化。t - PA; Ag与t - PA活性之间存在分离。5)住院第6天DIC评分未改善患者的t - PA; Ag水平高于评分改善的患者,但这些患者之间缺血器官的数量无差异。总之,尽管持续输注FOY,一些患者仍显示凝血酶持续产生。(摘要截选至250字)

相似文献

1
[An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].多器官功能衰竭患者弥散性血管内凝血的分析——分子标志物的变化及其临床应用
Rinsho Ketsueki. 1990 Nov;31(11):1774-9.
2
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.高血浆纤维蛋白原水平与弥散性血管内凝血患者的不良临床结局相关。
Am J Hematol. 2003 Jan;72(1):1-7. doi: 10.1002/ajh.10249.
3
[Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].[弥散性血管内凝血患者组织型纤溶酶原激活物 - 纤溶酶原激活物抑制剂 -1复合物的波动情况]
Rinsho Byori. 1994 Jul;42(7):707-12.
4
[Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].[纤溶酶-α2-纤溶酶抑制物复合物及血浆组织因子活性测定在弥散性血管内凝血患者中的临床应用价值]
Rinsho Byori. 1996 Aug;44(8):750-6.
5
[A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].一种用于血栓形成和生命预后的新型分子标志物——可溶性纤维蛋白单体-纤维蛋白原复合物(SF)测定的临床应用价值
Rinsho Byori. 2004 Apr;52(4):355-61.
6
[New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].[诊断与病情中的新有用参数或标志物。弥散性血管内凝血分析——主要是分子标志物]
Nihon Rinsho. 1993 Jan;51(1):37-42.
7
[Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
No To Shinkei. 1984 Oct;36(10):1009-14.
8
Posttrauma coagulation and fibrinolysis.创伤后凝血与纤溶
Crit Care Med. 1992 May;20(5):594-600. doi: 10.1097/00003246-199205000-00009.
9
Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.严重创伤后血浆中纤溶激活剂和抑制剂的水平
Blood Coagul Fibrinolysis. 1994 Feb;5(1):43-9.
10
[Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].[弥散性血管内凝血患者血浆抗凝血酶III和α2纤溶酶抑制物活性测定的临床相关性——分子标志物在弥散性血管内凝血病理生理学分析中的应用]
Rinsho Byori. 1994 Jan;42(1):45-55.